Piramal Enterprises Ltd (PEL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Piramal Enterprises Ltd (PEL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH16508D
  • |
  • Pages: 53
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Piramal Enterprises Ltd (PEL), is a provider of medicines and healthcare finance services. The company offers products such as Critical Care, Consumer Care, BST-CarGel, Phyto Medicines, Anaesthesias, Orthopedic medicines, Halothane, Isoflurane , Sevoflurane and other OTC related medicines. It also offers contract manufacturing and development services, pharma solutions, critical care solutions, imaging services, and other services such as fund management, structured investments and information management services. The company serves life sciences, financial services,health care, health care information management, specialty glass packaging and real estate sectors. It operates over 110 countries, including, India, Sri Lanka, Germany, Italy, the UK, France, Canada, the US and other countries. PEL is headquartered in Mumbai, Maharashtra, India.

Piramal Enterprises Ltd (PEL)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Piramal Enterprises Ltd, Medical Devices Deals, 2012 to YTD 2018 11

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deal Details 14

Asset Purchase 14

Piramal Critical Care Acquires Yargesa from Edenbridge Pharma 14

Piramal Enterprises Acquires Digeplex and Associated Brands from Shreya Life Sciences 15

Piramal Enterprises Acquires Intrathecal Therapy Business from Mallinckrodt for 203 Million 16

Piramal to Acquire Five Anesthesia and Pain Management Injectable Products from Janssen Pharma 17

Piramal Enterprises Plans to Acquire Over The Counter Business from Morepen Labs 18

Piramal Enterprises Acquires Five OTC Brands from Organon India and MSD for USD14 Million 19

Piramal Enterprises Acquires Caladryl Brand From Valeant Pharma 20

Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma 21

Private Equity 22

Piramal Enterprises Mulls Sale of Up to 20% Stake in OTC Drugs Business 22

Partnerships 23

Terumo Enters into Distribution Agreement with Piramal Critical Care 23

Cumberland Pharma Enters into Agreement with Piramal Critical Care 24

Piramal Enterprises Forms Joint Venture with Navin Fluorine International 25

Goodwin Biotech Enters Into Co-Development Agreement With Coldstream Labs For Cytotoxic Antibody Drug Conjugates 26

Piramal Enterprises Enters Into Co-Development Agreement With Tata Memorial Centre 27

Fujifilm Diosynth Biotech Enters Into Agreement With Piramal Healthcare To Develop Antibody Drug Conjugates 28

Licensing Agreements 29

Presage Biosciences Enters into Licensing Agreement with Piramal Enterprises 29

Equity Offering 30

Piramal Enterprises Plans to Raise Funds through Public Offering 30

Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities 31

Debt Offering 32

Piramal Enterprises Raises USD770 Million in Private Placement of Debentures 32

Piramal Enterprises Raises USD51.6 Million in Private Placement of Debentures 33

Piramal Enterprises to Raise USD19.38 Million in Private Placement of Debentures 34

Asset Transactions 35

Indoco Remedies Acquires Clinical Research Division from Piramal Enterprises 35

Acquisition 36

Piramal Enterprises Acquires Ash Stevens 36

Piramal Acquires Coldstream for USD30.6 Million 37

Third Avenue Management Acquires 1.26% Stake In Piramal Enterprises From Morgan Stanley For USD 21 Million 38

Piramal Healthcare Plans To Acquire Contract Manufacturing Companies 39

Piramal Healthcare Plans To Acquire Pharma Company In Europe 40

Piramal Enterprises Ltd-Key Competitors 41

Piramal Enterprises Ltd-Key Employees 42

Piramal Enterprises Ltd-Locations And Subsidiaries 43

Head Office 43

Other Locations & Subsidiaries 43

Recent Developments 46

Strategy And Business Planning 46

Mar 22, 2017: Piramal Pharma Solutions Augments Integrated Capabilities by Expanding Sterile Manufacturing Capabilities in Lexington, KY 46

Financial Announcements 47

Jul 30, 2018: Piramal Enterprises reports consolidated results for the first quarter ended June 30, 2018 47

May 28, 2018: Piramal Enterprises Limited announces Consolidated Results for the Full Year & Fourth Quarter ended 31 Mar 2018 49

Corporate Communications 51

Mar 20, 2017: Piramal Pharma Solutions Names Stuart E. Needleman as Chief Commercial Officer 51

Other Significant Developments 52

Oct 05, 2018: Piramal Pharma Solutions Announces the Launch of Xcelerate Integrated Solutions 52

Appendix 53

Methodology 53

About GlobalData 53

Contact Us 53

Disclaimer 53

List of Figures

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Piramal Enterprises Ltd, Medical Devices Deals, 2012 to YTD 2018 11

List of Tables

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Piramal Enterprises Ltd, Deals By Therapy Area, 2012 to YTD 2018 9

Piramal Enterprises Ltd, Medical Devices Deals, 2012 to YTD 2018 11

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

Piramal Critical Care Acquires Yargesa from Edenbridge Pharma 14

Piramal Enterprises Acquires Digeplex and Associated Brands from Shreya Life Sciences 15

Piramal Enterprises Acquires Intrathecal Therapy Business from Mallinckrodt for 203 Million 16

Piramal to Acquire Five Anesthesia and Pain Management Injectable Products from Janssen Pharma 17

Piramal Enterprises Plans to Acquire Over The Counter Business from Morepen Labs 18

Piramal Enterprises Acquires Five OTC Brands from Organon India and MSD for USD14 Million 19

Piramal Enterprises Acquires Caladryl Brand From Valeant Pharma 20

Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma 21

Piramal Enterprises Mulls Sale of Up to 20% Stake in OTC Drugs Business 22

Terumo Enters into Distribution Agreement with Piramal Critical Care 23

Cumberland Pharma Enters into Agreement with Piramal Critical Care 24

Piramal Enterprises Forms Joint Venture with Navin Fluorine International 25

Goodwin Biotech Enters Into Co-Development Agreement With Coldstream Labs For Cytotoxic Antibody Drug Conjugates 26

Piramal Enterprises Enters Into Co-Development Agreement With Tata Memorial Centre 27

Fujifilm Diosynth Biotech Enters Into Agreement With Piramal Healthcare To Develop Antibody Drug Conjugates 28

Presage Biosciences Enters into Licensing Agreement with Piramal Enterprises 29

Piramal Enterprises Plans to Raise Funds through Public Offering 30

Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities 31

Piramal Enterprises Raises USD770 Million in Private Placement of Debentures 32

Piramal Enterprises Raises USD51.6 Million in Private Placement of Debentures 33

Piramal Enterprises to Raise USD19.38 Million in Private Placement of Debentures 34

Indoco Remedies Acquires Clinical Research Division from Piramal Enterprises 35

Piramal Enterprises Acquires Ash Stevens 36

Piramal Acquires Coldstream for USD30.6 Million 37

Third Avenue Management Acquires 1.26% Stake In Piramal Enterprises From Morgan Stanley For USD 21 Million 38

Piramal Healthcare Plans To Acquire Contract Manufacturing Companies 39

Piramal Healthcare Plans To Acquire Pharma Company In Europe 40

Piramal Enterprises Ltd, Key Competitors 41

Piramal Enterprises Ltd, Key Employees 42

Piramal Enterprises Ltd, Other Locations 43

Piramal Enterprises Ltd, Subsidiaries 43

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Piramal Enterprises Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17250
Site License
USD 500 INR 34500
Corporate User License
USD 750 INR 51750

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com